- Home
- MRNA vs GPC Comparison
MRNA vs GPC Comparison
Compare MRNA & GPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- GPC
- Stock Information
- Founded
- MRNA 2010
- GPC 1928
- Country
- MRNA United States
- GPC United States
- Employees
- MRNA N/A
- GPC N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- GPC Automotive Aftermarket
- Sector
- MRNA Health Care
- GPC Consumer Discretionary
- Exchange
- MRNA Nasdaq
- GPC Nasdaq
- Market Cap
- MRNA 16.0B
- GPC 16.9B
- IPO Year
- MRNA 2018
- GPC N/A
- Fundamental
- Price
- MRNA $28.56
- GPC $118.75
- Analyst Decision
- MRNA Hold
- GPC Buy
- Analyst Count
- MRNA 20
- GPC 8
- Target Price
- MRNA $54.82
- GPC $137.63
- AVG Volume (30 Days)
- MRNA 9.3M
- GPC 1.6M
- Earning Date
- MRNA 05-01-2025
- GPC 04-17-2025
- Dividend Yield
- MRNA N/A
- GPC 3.48%
- EPS Growth
- MRNA N/A
- GPC N/A
- EPS
- MRNA N/A
- GPC 6.47
- Revenue
- MRNA $3,236,000,000.00
- GPC $23,486,569,000.00
- Revenue This Year
- MRNA N/A
- GPC $3.42
- Revenue Next Year
- MRNA $23.65
- GPC $4.13
- P/E Ratio
- MRNA N/A
- GPC $18.31
- Revenue Growth
- MRNA N/A
- GPC 1.72
- 52 Week Low
- MRNA $29.25
- GPC $112.74
- 52 Week High
- MRNA $170.47
- GPC $164.45
- Technical
- Relative Strength Index (RSI)
- MRNA 34.78
- GPC 44.46
- Support Level
- MRNA $31.52
- GPC $117.66
- Resistance Level
- MRNA $34.87
- GPC $121.64
- Average True Range (ATR)
- MRNA 1.74
- GPC 2.55
- MACD
- MRNA -0.37
- GPC -0.56
- Stochastic Oscillator
- MRNA 15.53
- GPC 16.09
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About GPC Genuine Parts Company
Genuine Parts sells aftermarket automotive parts (about 60% of sales) and industrial products (40% of sales) in the United States and internationally. The automotive segment primarily acts as a distributor to its network of 9,800 global retail locations of which about two thirds are independently owned and operated. we estimate Genuine serves around 6,000 retail locations in the US operating under the Napa Auto Parts brand, with about 80% of end market sales derived from professional customers. Its industrial segment, primarily operating under the Motion banner in the United States, serves as a leading distributor of bearings, power transmission, and other industrial products to more than 200,000 maintenance, repair, and original equipment manufacturer clients.